Medtronic launches ‘world’s smallest pacemaker’ in Dhaka

The smallest pacemaker in the world, Micra, developed by the global medical technology provider Medtronic has been implanted successfully in a patient in Bangladesh. The aspects of the pacemaker was discussed by Dr Shams Munwar at press conference organized by Medtronic, says a press release.
A 54-year- old patient Md Abu Sulaiman with Braycardia was treated with Micra in Apollo Hospital Dhaka. Bradycardia is a condition characterized by a slow or irregular heart rhythm, usually fewer than 60 beats per minute. At this rate, the heart is unable to pump enough oxygen-rich blood to the body during normal activity or exercise, causing dizziness, fatigue, shortness of breath or fainting spells.
This first implant in Dhaka was performed by Dr. Shams Munwar, Chief Cardiologist of the hospital.  size of a big vitamin capsule, 0.8cc, the pacemaker is very easy to send to the heart through a catheter inserted in femoral vein, requiring no surgical incision. Therefore, it leaves no visible mark or any complication. It weighs only 2 gram, which is one-tenth of a traditional pacemaker and is less than a coin.
The longevity of Micra, which is approved by US Food & Drug Administration (FDA), is 4 years more than conventional pacemaker.
Pacemakers gear up the heart rate by sending electric signals to the heart. Pacemakers are recommended when the heart rate falls below 60 beats per minute.
It takes only 15 minutes for the whole implantation process to take place while regular pacemaker takes more than an hour. The patient can be discharged on the same day they get admitted.
Unlike traditional pacemakers, Micra TPS does not require cardiac wire (lead) and a surgical “pocket” under the skin to deliver a pacing therapy.
It is proved to be effective through its trial on 744 patients in 56 centers around the world. The trial incorporated patients with chronic lung diseases, ages from 21 to 94 and weights from 41 to 148 kilograms. Patients under trial hailed from different parts of the world including Asia-Pacific, Europe and United States.
With a 12-year battery life on average, the pacemaker is approved for full-body MRI scans. It doesn’t require any wires, known as leads. It responds to patients’ activity levels by automatically adjusting therapy.

Medtronic launches worlds smallest pacemaker in Dhaka

The smallest pacemaker in the world, Micra, developed by the global medical technology provider Medtronic has been implanted successfully in a patient in Bangladesh. The aspects of the pacemaker was discussed by Dr Shams Munwar at press conference organized by Medtronic, says a press release. A 54-year- old patient Md Abu Sulaiman with Braycardia was treated with Micra in Apollo Hospital Dhaka. Bradycardia is a condition characterized by a slow or irregular heart rhythm, usually fewer than 60 beats per minute. At this rate, the heart is unable to pump enough oxygen-rich blood to the body during normal activity or exercise, causing dizziness, fatigue, shortness of breath or fainting spells. This first implant in Dhaka was performed by Dr. Shams Munwar, Chief Cardiologist of the hospital. size of a big vitamin capsule, 0.8cc, the pacemaker is very easy to send to the heart through a catheter inserted in femoral vein, requiring no surgical incision. Therefore, it leaves no visible mark or any complication. It weighs only 2 gram, which is one-tenth of a traditional pacemaker and is less than a coin. The longevity of Micra, which is approved by US Food amp; Drug Administration (FDA), is 4 years more than conventional pacemaker. Pacemakers gear up the heart rate by sending electric signals to the heart. Pacemakers are recommended when the heart rate falls below 60 beats per minute. It takes only 15 minutes for the whole implantation process to take place while regular pacemaker takes more than an hour. The patient can be discharged on the same day they get admitted. Unlike traditional pacemakers, Micra TPS does not require cardiac wire (lead) and a surgical pocket under the skin to deliver a pacing therapy. It is proved to be effective through its trial on 744 patients in 56 centers around the world. The trial incorporated patients with chronic lung diseases, ages from 21 to 94 and weights from 41 to 148 kilograms. Patients under trial hailed from different parts of the world including Asia-Pacific, Europe and United States. With a 12-year battery life on average, the pacemaker is approved for full-body MRI scans. It doesnt require any wires, known as leads. It responds to patients activity levels by automatically adjusting therapy.